| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/14/2005 | WO2005033330A2 Fluorescent probes for use in protein kinase inhibitor binding assay |
| 04/14/2005 | WO2005033327A2 Methods and compositions for the diagnosis of sepsis |
| 04/14/2005 | WO2005033326A2 Method of extending single-stranded nucleic acid, single-stranded nucleic acid extending apparatus and dna chip |
| 04/14/2005 | WO2005033308A1 Schizophrenia-associated protein and gene coding for the same |
| 04/14/2005 | WO2005033297A1 Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells |
| 04/14/2005 | WO2005033296A1 Methods of surface modification to enhance cell adhesion |
| 04/14/2005 | WO2005033286A2 Compositions and methods for synthesizing, purifying and detecting biomolecules |
| 04/14/2005 | WO2005033284A2 Compositions and methods for gene expression |
| 04/14/2005 | WO2005033275A2 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
| 04/14/2005 | WO2005033267A2 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 04/14/2005 | WO2005033266A2 Regulation of acheron expression |
| 04/14/2005 | WO2005033245A1 Fluorescent compound |
| 04/14/2005 | WO2005033158A2 Attachment of molecules to surfaces |
| 04/14/2005 | WO2005033149A1 Receptor specific binder discovery using intramolecular acyl migration induced dynamic carbohydrate library |
| 04/14/2005 | WO2005033147A1 Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain |
| 04/14/2005 | WO2005033132A2 Igf binding proteins |
| 04/14/2005 | WO2005033126A1 Cell surface marker |
| 04/14/2005 | WO2005032719A1 Clinical analysis system |
| 04/14/2005 | WO2005032692A1 Device and method for measuring elemental sulfur in gas in gas lines |
| 04/14/2005 | WO2005032689A1 Filter snapper |
| 04/14/2005 | WO2005032595A2 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 04/14/2005 | WO2005032589A1 Prevention and treatment for gvhd |
| 04/14/2005 | WO2005032585A1 Pharmaceutical compositions containing human papilloma virus antigens |
| 04/14/2005 | WO2005032561A1 INVENTION RELATING TO FUNCTION OF HIV-Vpr |
| 04/14/2005 | WO2005032496A2 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 04/14/2005 | WO2005032491A2 Methods and compositions for mycoplasma pneumoniae exotoxins |
| 04/14/2005 | WO2005032487A2 Angiotensin-converting enzyme-2 as a receptor for the sars coronavirus |
| 04/14/2005 | WO2005032458A2 Dye solution and method for detecting anhydrous ammonia |
| 04/14/2005 | WO2005032455A2 Combinatorially selected phosphorodithioate aptamer targeting ap-1 |
| 04/14/2005 | WO2005032454A2 Anti-muc-1 single chain antibodies for tumor targeting |
| 04/14/2005 | WO2005032372A1 Test device for analyzing body fluids |
| 04/14/2005 | WO2005032330A2 Zintrodes, multitrodes and uses thereof |
| 04/14/2005 | WO2005032329A2 Methods and compositions for identifying anti-hcv agents |
| 04/14/2005 | WO2005032328A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis |
| 04/14/2005 | WO2005024433A3 Building blocks for artificial receptors |
| 04/14/2005 | WO2005017522A3 Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy |
| 04/14/2005 | WO2005017180A3 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 04/14/2005 | WO2005008225B1 Device for counting cells and method for manufacturing the same |
| 04/14/2005 | WO2005003778A3 A method for identifying a synthetic molecule having affinity towards a target |
| 04/14/2005 | WO2005003728A3 Measuring soil light response |
| 04/14/2005 | WO2005000196A3 Inhibition of egr-1 expression by rpar-ϝ agonista and related compositions and methods |
| 04/14/2005 | WO2004113950A8 Method and apparatus for monitoring and measuring oil spills |
| 04/14/2005 | WO2004113515A3 Tissue modeling in embryonic stem (es) cell system |
| 04/14/2005 | WO2004111637A3 Dendritic cells for prognosis of metastatic evolution of tumors |
| 04/14/2005 | WO2004105575A3 A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels |
| 04/14/2005 | WO2004103939A8 Assay method and apparatus |
| 04/14/2005 | WO2004098487A3 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 5 (tmprss5) |
| 04/14/2005 | WO2004097409A3 Hemostasis analyzer and method |
| 04/14/2005 | WO2004097372A3 Element-coded affinity tags |
| 04/14/2005 | WO2004097052A3 Methods for prognosis and treatment of solid tumors |
| 04/14/2005 | WO2004097036A3 Optical detector for enzyme activation |
| 04/14/2005 | WO2004096990A3 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice |
| 04/14/2005 | WO2004096989A3 Single chain antigen-binding polypeptides for polymer conjugation |
| 04/14/2005 | WO2004087884A3 TARGETING ENZYMES OF THE tRNA SPLICING PATHWAY FOR IDENTIFICATION OF ANTI-FUNGAL AND/OR ANTI-PROLIFERATIVE MOLECULES |
| 04/14/2005 | WO2004087865A3 The preparation and application of ligand-biopolymer conjugates |
| 04/14/2005 | WO2004084263A3 Integrated apparatus and methods for treating liquids |
| 04/14/2005 | WO2004082363A3 Sensor assembly and methods of making and using same |
| 04/14/2005 | WO2004078233A3 Cartridge having an integrated collection element for point of care system |
| 04/14/2005 | WO2004077011A3 Generic method for latex agglutination assays |
| 04/14/2005 | WO2004075010A3 Statistically identifying an increased risk for disease |
| 04/14/2005 | WO2004074506A3 Polynucleotide sequences and corresponding encoded polypeptides of particular secreted and membrane-bound proteins overexpressed in certain cancers |
| 04/14/2005 | WO2004073486A3 Diagnostic device and method |
| 04/14/2005 | WO2004072105A3 Iap-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods |
| 04/14/2005 | WO2004071427A3 Screening and treatment methods for prevention of preterm delivery |
| 04/14/2005 | WO2004070643A3 Method for predicting protein function |
| 04/14/2005 | WO2004070013A3 Use of islet 1 as a marker for isolating or generating stem cells |
| 04/14/2005 | WO2004068105A3 Immunoassay and method of use |
| 04/14/2005 | WO2004063704A3 Vitamin d assay |
| 04/14/2005 | WO2004060294A3 Functionalization of immobilized proteins |
| 04/14/2005 | WO2004060293A3 Methods and compositions for protection against thrombolysis-associated reperfusion injury |
| 04/14/2005 | WO2004058158A3 Treatment of metastatic cancer with the b-subunit of shiga toxin |
| 04/14/2005 | WO2004047767A3 Methods for identifying risk of breast cancer and treatments thereof |
| 04/14/2005 | WO2004047612A3 Methods of therapy and diagnosis |
| 04/14/2005 | WO2004042347A3 Compositions and methods for detection and isolation of phosphorylated molecules |
| 04/14/2005 | WO2004039955A3 Modulators of angiogenesis and tumorigenesis |
| 04/14/2005 | WO2004039307A3 Methods and compositions for diagnosing and treating companion animal cancer |
| 04/14/2005 | WO2004031732A3 Nanocrystals in ligand boxes exhibiting enhanced chemical, photochemical, and thermal stability, and methods of making the same |
| 04/14/2005 | WO2004031724A3 Apparatus and method for expression and capture of biomolecules and complexes on adsorbent surfaces |
| 04/14/2005 | WO2004031105A3 Use of a33 antigens and jam-it |
| 04/14/2005 | WO2004025559A9 Diffraction grating-based optical identification element |
| 04/14/2005 | WO2004022714A3 Organic species that facilitate charge transfer to or from nanostructures |
| 04/14/2005 | WO2004020597A3 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 04/14/2005 | WO2004013609A3 Use of biomarkers for detecting ovarian cancer |
| 04/14/2005 | WO2004011485A3 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 04/14/2005 | WO2003086453A9 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis |
| 04/14/2005 | WO2003084475A3 INHIBITORS OF THE S100-p53 PROTEIN-PROTEIN INTERACTION AND METHOD OF INHIBITING CANCER EMPLOYING THE SAME |
| 04/14/2005 | WO2003073983A3 Methods and compositions in treating pain using diacylglycerol kinase epsilon |
| 04/14/2005 | WO2003070971A3 Modulators of paraptosis and related methods |
| 04/14/2005 | WO2003029278A3 Il10-r: modulators of lymphocyte activation |
| 04/14/2005 | WO2003027228A3 Receptors and membrane-associated proteins |
| 04/14/2005 | WO2003002753A3 Diagnostic assays for parvovirus b19 |
| 04/14/2005 | WO2002079417A3 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 04/14/2005 | US20050080652 User-based health monitoring |
| 04/14/2005 | US20050080570 Predicting probabilities of achieving a desired minimum trough level for an anti-infective agent |
| 04/14/2005 | US20050080324 Blood sugar level measuring method and apparatus |
| 04/14/2005 | US20050080254 Method for producing reactive cyclodextrins, textile material provided with same, and use of said cyclodextrin derivatives |
| 04/14/2005 | US20050080243 Screening for enzyme inhibitors; signal transduction passageways' chelation enhancement fluorescence |
| 04/14/2005 | US20050080242 Fluorescence assay for kinase activity |
| 04/14/2005 | US20050080233 Expression vector comprising nucleotide sequences coding bacterial outer membrane protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 04/14/2005 | US20050080102 Compound and uses thereof |